BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND LDH
211 results:

  • 1. Cellular senescence in testicular cancer. Is there a correlation with the preoperative markers and the extent of the tumor? An experimental study.
    Tatanis V; Veroutis D; Pantelis P; Theocharous G; Sarlanis H; Georgiou A; Peteinaris A; Natsos A; Moulavasilis N; Kavantzas N; Kotsinas A; Adamakis I
    Arch Ital Urol Androl; 2024 Mar; 96(1):12246. PubMed ID: 38441175
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Extragonadal germ cell tumor: A case report and review of the literature].
    Li P; Wu D; Xu XF; Fu D; Jia RP; Ge JP
    Zhonghua Nan Ke Xue; 2022 Nov; 28(11):1026-1030. PubMed ID: 37846120
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
    Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
    Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
    Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
    [No Abstract]    [Full Text] [Related]  

  • 5. Absolute monocyte count has a diagnostic role in distinguishing tumor marker-negative TGCT from benign testicular tumor via CCL2 regulation.
    Cao L; Chang Q; Sun J; Pang S; Fan Y; Liu J
    Medicine (Baltimore); 2023 Jun; 102(25):e34114. PubMed ID: 37352031
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of testicular Germ Cell Tumors.
    Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
    Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Εmerging Biomarkers in the Diagnosis and Treatment of testicular Tumors.
    Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
    Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.
    Dieckmann KP; Dumlupinar C; Grobelny F; Utschig J; Klemke M; Ahmed Saad EM; Wülfing C; Pichlmeier U; Isbarn H; Belge G
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7079-7090. PubMed ID: 36869885
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
    Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
    Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Management of testicular Germ Cell Tumor With Somatic-Type Malignancy.
    Konneh B; Leonard AJ; Lafin JT; Jia L; Bagrodia A
    Oncology (Williston Park); 2022 Jun; 36(6):375-377. PubMed ID: 35723941
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Biomarkers in testicular cancer.].
    Mayor-de-Castro J; Aragón-Chamizo J; Caño-Velasco J; Hernández-Fernández C
    Arch Esp Urol; 2022 Mar; 75(2):113-117. PubMed ID: 35332880
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Platelet-to-Lymphocyte Ratio as an Indicator to Predict Decreased Carbon Monoxide Diffusion of the Lung in Patients with testicular cancer.
    Karakaya S; Karadag I; Ozdilekcan C; Durmusoglu E; Ates O; Cakmak Oksuzoglu OB
    J Coll Physicians Surg Pak; 2022 Mar; 32(3):369-372. PubMed ID: 35148592
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
    Barragán-Carrillo R; Mateos-Corella S; Ortiz-Hidalgo C; Izquierdo-Echavarri E; Castillejos-Molina R; Angel M; Barragan-Arteaga I; Flaig T; Bourlon MT
    Oncology (Williston Park); 2021 Dec; 35(12):816-819. PubMed ID: 35088997
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [ADENOCARCINOMA OF THE RETE TESTIS WITH METASTASIS OF THE PENILE AND LUNG: A CASE REPORT].
    Noguchi T; Osaka K; Shibata Y; Koizumi M; Suzuki T; Kishida T; Okubo Y; Kameda Y
    Nihon Hinyokika Gakkai Zasshi; 2022; 113(2):78-81. PubMed ID: 37081657
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer.
    Brandt MP; Ruf C; Dieckmann KP; Syring I; Ruckes C; Nestler T; Schmelz HU; Dotzauer R; Hiester A; Albers P; Nettersheim D; Bolenz C; Loosen SH; Heidenreich A; Pfister D; Haferkamp A; Zengerling F; Paffenholz P;
    World J Urol; 2022 Feb; 40(2):327-334. PubMed ID: 34854948
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Predictors of Venous Thromboembolism in Patients With testicular Germ Cell Tumors: A Retrospective Study.
    Abdel-Razeq H; Tamimi F; Abdel-Razeq R; Salah S; Omari Z; Salama O; Abufara A; Al-Tell A; Qahoush H; Nasman A; Taqash A; Alhalaseh Y; Bater R
    Clin Appl Thromb Hemost; 2021; 27():10760296211024756. PubMed ID: 34121471
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
    Beyer J; Collette L; Sauvé N; Daugaard G; Feldman DR; Tandstad T; Tryakin A; Stahl O; Gonzalez-Billalabeitia E; De Giorgi U; Culine S; de Wit R; Hansen AR; Bebek M; Terbuch A; Albany C; Hentrich M; Gietema JA; Negaard H; Huddart RA; Lorch A; Cafferty FH; Heng DYC; Sweeney CJ; Winquist E; Chovanec M; Fankhauser C; Stark D; Grimison P; Necchi A; Tran B; Heidenreich A; Shamash J; Sternberg CN; Vaughn DJ; Duran I; Bokemeyer C; Patrikidou A; Cathomas R; Assele S; Gillessen S;
    J Clin Oncol; 2021 May; 39(14):1553-1562. PubMed ID: 33729863
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
    Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser CD; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Raggi D; Aurilio G; Casadei C; Hentrich M; Tran B; Dieckmann KP; Brito M; Ruf C; Mazzocca A; Vincenzi B; Stahl O; Bokemeyer C; Oing C
    World J Urol; 2021 Sep; 39(9):3407-3414. PubMed ID: 33683412
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prognostic importance of neutrophil-to-lymphocyte ratio in testicular cancer.
    Arıman A; Merder E
    Urologia; 2021 Aug; 88(3):200-205. PubMed ID: 33568012
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. testicular germ cell tumors type 2 have high RNA expression of
    von Eyben FE; Parraga-Alava J; Tu SM
    Asian J Androl; 2021; 23(4):357-362. PubMed ID: 33565425
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.